Wistar Institute ( Wistar Institute )

Wistar Institute

Wistar Institute's picture

The Wistar Institute is the nation’s first independent institution devoted to medical research and training. The Wistar Institute has evolved from its beginnings as an anatomical teaching museum to its present-day status as an international leader in basic biomedical research.

In 1972, The Wistar Institute was designated a National Cancer Institute Cancer Center in basic research—a distinction it holds to this day.

Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

Wistar Institute press release, blog etc

03/06/2018 - 08:10 Fundamental Step Found in the Cellular Response to Stress Caused by Pathological and Pharmacological Insults
02/22/2018 - 13:31 Variant of the p53 Gene Increased Tumor Cell Metabolism
02/13/2018 - 13:46 Wistar Researchers Garnered More Than $6.5M in Funding to Support New Discoveries in Cancer & Infectious Disease
02/12/2018 - 08:48 New Targeted Therapeutic Approach to Combat Ovarian Cancer
01/24/2018 - 23:36 Wistar's David Weiner, Ph.D., Named President of the International Society for Vaccines
01/17/2018 - 23:41 The Wistar Institute Awarded More Than $1.4 Million to Create a Malaria Vaccine Through Synthetic DNA-Based Technology
01/17/2018 - 00:28 When it Comes to Science, its a Small, Small World
01/14/2018 - 23:59 Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early Life
01/11/2018 - 00:28 Wistars Chi Van Dang, M.D., Ph.D., Named Editor-in-Chief of AACR Journal Cancer Research
12/21/2017 - 07:22 Wistar Scientists Develop Improved DNA Vaccine Targeting the Tumor Microenvironment
12/19/2017 - 09:42 Novel Combination Therapy Shown to Be Effective in Ovarian
12/14/2017 - 13:43 Wistar Scientists Identify Mechanism of Impaired Dendritic Cell Function that Weakens Immune and Therapeutic Response to Cancer
11/14/2017 - 16:56 Scientists Generate a Comprehensive Collection of Pre-clinical Models for Melanoma Research
11/14/2017 - 05:35 ITUS Corporation Licenses CAR-T Technology from The Wistar Institute
11/13/2017 - 09:54 Scientists Identified a Cellular Network That Short Circuits the Antitumor Effect of Novel Immunotherapy
11/13/2017 - 07:06 Wistar Scientists Identified a Cellular Network That Short Circuits the Antitumor Effect of Novel Immunotherapy
11/06/2017 - 10:09 The Wistar Institute Awarded More Than $16.5M in Grants to Fund Cancer & Infectious Disease Research and Training
11/02/2017 - 06:51 Wistar Expands Collaboration & Signs Exclusive License Agreement with Mans Best Friend Therapeutics to Develop Novel Veterinary Vaccine Technology